Pharmaceuticals - , ,
Pharos company, the owner of AvvalinGhadam , provides one of the world's most comprehensive programs for detecting clinically significant inherited disorders and Iran's First most comprehensive newborn screening. Our services are designed to identify treatable disorders very early in life before irreversible health damage occurs. We strive to improve the health of the most fragile members of our community, our children. The mission of AvvalinGhadam is to provide high quality newborn screening services to improve and save children's lives through early detection and intervention. We continually emphasize the core values of integrity, respect, dignity, and compassion for each baby in our care.